Articles from Onsera Health

Onsera Health Strengthens Cardiometabolic Care Delivery with Eli Lilly's(R) Oral GLP-1 Foundayo(R)
The addition of Foundayo (orforglipron) provides participants with an FDA-approved, injection-free, GLP-1 treatment for people living with excess weight within a structured personalized care platform
By Onsera Health · Via ACCESS Newswire · August 5, 2026
Articles from Onsera Health | FWNBC